Close

Teva Pharma (TEVA) Announces FDA Acceptance of Resubmitted NDA for SD-809 for Treatment of Chorea Associated with HD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Teva Pharma (TEVA) Announces FDA Acceptance of Resubmitted NDA for SD-809 for Treatment of Chorea Associated with HD